Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ATOS NASDAQ:DVLT NASDAQ:MVIS NYSEAMERICAN:TRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATOSAtossa Genetics$2.04+5.7%$4.22$1.70▼$19.35$16.62M1.25306,076 shs143,063 shsDVLTDatavault AI$0.40+15.4%$0.49$0.25▼$4.10$299.45M0.3223.64 million shs105.01 million shsMVISMicrovision$0.42+27.1%$0.52$0.26▼$1.73$112.70M1.2411.61 million shs22.64 million shsTRXTRX Gold$0.84+1.8%$1.06$0.33▼$2.80$270.16M0.31.81 million shs1.20 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATOSAtossa Genetics+5.70%+16.57%-60.08%-61.94%-83.50%DVLTDatavault AI+15.40%+18.72%-27.42%-43.99%-38.36%MVISMicrovision+27.06%+33.47%-31.23%-34.57%-62.23%TRXTRX Gold+1.82%+6.73%-25.66%-44.00%+151.50%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATOSAtossa Genetics$2.04+5.7%$4.22$1.70▼$19.35$16.62M1.25306,076 shs143,063 shsDVLTDatavault AI$0.40+15.4%$0.49$0.25▼$4.10$299.45M0.3223.64 million shs105.01 million shsMVISMicrovision$0.42+27.1%$0.52$0.26▼$1.73$112.70M1.2411.61 million shs22.64 million shsTRXTRX Gold$0.84+1.8%$1.06$0.33▼$2.80$270.16M0.31.81 million shs1.20 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATOSAtossa Genetics+5.70%+16.57%-60.08%-61.94%-83.50%DVLTDatavault AI+15.40%+18.72%-27.42%-43.99%-38.36%MVISMicrovision+27.06%+33.47%-31.23%-34.57%-62.23%TRXTRX Gold+1.82%+6.73%-25.66%-44.00%+151.50%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATOSAtossa Genetics 2.00Hold$24.501,100.98% UpsideDVLTDatavault AI 2.00Hold$3.00642.76% UpsideMVISMicrovision 2.00Hold$2.50501.68% UpsideTRXTRX Gold 3.00Buy$2.28170.83% UpsideCurrent Analyst Ratings BreakdownLatest DVLT, MVIS, ATOS, and TRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2026ATOSAtossa Genetics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/8/2026TRXTRX Gold HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.306/2/2026MVISMicrovision Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/22/2026ATOSAtossa Genetics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/11/2026ATOSAtossa Genetics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/24/2026DVLTDatavault AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026ATOSAtossa Genetics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/16/2026TRXTRX Gold HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.304/10/2026ATOSAtossa Genetics Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$120.00 ➝ $24.00(Data available from 7/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATOSAtossa GeneticsN/AN/AN/AN/A$4.57 per shareN/ADVLTDatavault AI$39.09M8.84N/AN/A$0.41 per share0.99MVISMicrovision$1.21M118.35N/AN/A$0.18 per share2.31TRXTRX Gold$57.61M4.77$0.02 per share51.83$0.26 per share3.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATOSAtossa Genetics-$34.77M-$3.21N/AN/AN/AN/A-84.91%-72.36%8/11/2026 (Estimated)DVLTDatavault AI-$78.99M-$0.92N/AN/AN/A-292.68%-64.71%-52.12%N/AMVISMicrovision-$94.98M-$0.31N/AN/AN/A-5,887.77%-139.20%-72.51%8/12/2026 (Estimated)TRXTRX Gold$690K-$0.01N/A7.64N/A-23.45%-12.62%-8.05%N/ALatest DVLT, MVIS, ATOS, and TRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026MVISMicrovision-$0.05-$0.08-$0.03-$0.08$0.20 million$0.94 million5/8/2026Q1 2026ATOSAtossa Genetics-$0.99-$1.11-$0.12-$1.11N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthATOSAtossa GeneticsN/AN/AN/AN/AN/ADVLTDatavault AIN/AN/AN/AN/AN/AMVISMicrovisionN/AN/AN/AN/AN/ATRXTRX GoldN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATOSAtossa GeneticsN/A4.924.92DVLTDatavault AI0.024.624.58MVISMicrovisionN/A1.050.97TRXTRX Gold0.032.371.52Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATOSAtossa Genetics12.74%DVLTDatavault AI0.66%MVISMicrovision30.90%TRXTRX Gold1.06%Insider OwnershipCompanyInsider OwnershipATOSAtossa Genetics9.80%DVLTDatavault AI7.70%MVISMicrovision1.19%TRXTRX Gold2.25%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATOSAtossa Genetics88.61 million7.77 millionOptionableDVLTDatavault AI40855.56 million789.68 millionN/AMVISMicrovision350344.65 million340.55 millionOptionableTRXTRX Gold120327.47 million320.10 millionOptionableDVLT, MVIS, ATOS, and TRX HeadlinesRecent News About These CompaniesTRX Gold (NYSEAMERICAN:TRX) Stock Price Up 1.8% - What's Next?2 hours ago | americanbankingnews.comVirtune adds four new crypto assets to the Virtune Stablecoin Index ETP: Ethena (ENA), Canton (CC), TRON (TRX), and BNB (BNB)July 1 at 6:03 AM | globenewswire.comFocused on Self-Funded Growth – TRX Gold Corporation (TSX: TRX) | GCFF Virtual 2026 Precious Metals Conference (Asia Pacific)June 26, 2026 | nai500.comNTRX Gold 3Q Output Jumps, Guidance Reaffirmed as Expansion Plans ProgressJune 5, 2026 | marketwatch.comTRX Gold Reports Q3 2026 Production on Record Throughput, Reaffirms Guidance, and Accelerates Plant ExpansionJune 5, 2026 | globenewswire.comTRX Gold Corporation (TRX): 10 Best Gold Mining Stocks to Buy as Central Banks Buy BullionMay 17, 2026 | finance.yahoo.comTwenty-Three Kilometres of Veins, Three Continents of Optionality: An Argentine Discovery Story Lines Up the DrillMay 14, 2026 | markets.businessinsider.comTRX Gold (TSX:TRX) Is Up 11.4% After Boosting Buckreef Recoveries And Mill Capacity Plans – Has The Bull Case Changed?May 9, 2026 | finance.yahoo.comNew Recovery Rates and Expansion Make TRX Gold Corporation (TRX) One of the Top Oversold Canadian Stocks to Invest InMay 8, 2026 | finance.yahoo.comTRX Gold: Down 60% From Highs, And The Catalyst List Is GrowingMay 8, 2026 | seekingalpha.comIs TRX Gold Corporation Among the Best Gold Mining Companies to Invest In According to Wall Street?April 28, 2026 | finance.yahoo.comTRX Gold Advances Toward Larger Scale, Higher Margin ProductionApril 23, 2026 | finance.yahoo.comAssessing TRX Gold’s Valuation After Buckreef Production Gains And Plant Expansion ProgressApril 20, 2026 | finance.yahoo.comTRX Gold Corp (TRX) Q2 2026 Earnings Call Highlights: Record Gold Production and Financial ...April 16, 2026 | finance.yahoo.comTRX Gold (TSX:TRX) Is Down 7.8% After Buckreef Expansion Plans Deepen Losses - What's ChangedApril 15, 2026 | finance.yahoo.comTRX Gold beats revenue estimates on record productionApril 15, 2026 | in.investing.comTRX Gold Reports Second Quarter 2026 ResultsApril 15, 2026 | globenewswire.comTRX Gold Reports Robust Recovery Rates from Recent Study and Significant Increase in Plant Expansion ScopeApril 8, 2026 | globenewswire.comTRX Gold Is A Conditional Buy (A Technical Analysis)April 4, 2026 | seekingalpha.comTRX Gold: Self-Funded Growth Beyond The Gold RallyApril 4, 2026 | seekingalpha.comGold at $5,000—3 Mining Stocks for the Next Gold Rush...January 27, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDVLT, MVIS, ATOS, and TRX Company DescriptionsAtossa Genetics NASDAQ:ATOS$2.04 +0.11 (+5.70%) Closing price 07/1/2026 04:00 PM EasternExtended Trading$1.98 -0.06 (-3.19%) As of 04:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.Datavault AI NASDAQ:DVLT$0.40 +0.05 (+15.40%) Closing price 07/1/2026 04:00 PM EasternExtended Trading$0.40 0.00 (-0.47%) As of 04:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Datavault AI Inc., a data sciences technology company, owns and operates data management and supercomputer platforms. It offers data technology and software solutions. The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025. Datavault AI Inc. was incorporated in 2010 and is headquartered in Beaverton, Oregon.Microvision NASDAQ:MVIS$0.42 +0.09 (+27.06%) Closing price 07/1/2026 04:00 PM EasternExtended Trading$0.39 -0.02 (-5.17%) As of 04:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MicroVision, Inc. develops and sells lidar sensors and software used in automotive safety and autonomous driving applications. It offers a suite of light detection and ranging (lidar) sensors and perception; and validation software for automotive OEMs, advanced driver-assistance systems, and autonomous vehicle applications, as well as non-automotive applications including industrial, robotics, and smart infrastructure. The company also provides MAVIN DR, a dynamic view lidar system, which combines short, medium, and long range sense and field of view into one form; lidar sensors under the MOVIA brand name; and MOSAIK, a software that automates manual data classification or annotation process. In addition, it provides engineering services for its hardware and software products. The company markets its products to customers directly, through trade shows, and its website. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.TRX Gold NYSEAMERICAN:TRX$0.84 +0.02 (+1.82%) Closing price 07/1/2026 04:10 PM EasternExtended Trading$0.84 +0.01 (+0.60%) As of 04:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TRX Gold Corporation engages in the exploration, development, and production of mineral property interests in the United Republic of Tanzania. The company primarily explores for gold deposits. It holds interests in the Buckreef gold project that comprises a single Special Mining License covering an area of 16.04 square kilometers and 12 Prospecting Licenses covering 98.19 square kilometers located in north-central Tanzania. The company was formerly known as Tanzanian Gold Corporation and changed its name to TRX Gold Corporation in May 2022. TRX Gold Corporation was incorporated in 1990 and is based in Oakville, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks AirJoule Unveils Prime System, Clearing Path to Commercialization Comcast’s NBCUniversal Split Puts Broadband Back in Focus Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets Ouster Is Breaking Out as a Physical AI Leader: Here's What's Driving the Move Meta’s WhatsApp Shakeup Could Put India at the Center of Its Next Growth Push Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
